← Open Payments lookup

CAROL ANTEQUERA: Open Payments

NPI 1063710549 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$16,998 in 52 payments from 15 companies in 2025. Trend: 2023 $22,247 · 2024 $35,916 · 2025 $16,998

Speaker / faculty: $8,215Consulting: $6,215Food & beverage: $1,491Travel & lodging: $1,077
CompanyPaymentsAmount
GENZYME CORPORATION9$4,266
ABBVIE INC.6$2,621
Regeneron Healthcare Solutions, Inc.4$2,397
EVOKE PHARMA, INC.5$2,248
Salix Pharmaceuticals, a division of Bausch Health US, LLC10$1,948
Regeneron Pharmaceuticals, Inc.3$1,221
Novo Nordisk Inc2$1,182
Ardelyx, Inc.4$778
IRONWOOD PHARMACEUTICALS, INC1$83
Aimmune Therapeutics, Inc.3$80

Products named: DUPIXENT, GIMOTI, TRULANCE, IBSRELA, XIFAXAN, Linzess, ZENPEP, Cologuard Collection Kit.

Industry payments across FL — which companies pay providers there.